P3 Health Partners Inc.
PIII
$2.74
-$0.34-11.04%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 354.71M | 345.25M | 355.79M | 373.23M | 353.83M |
| Total Other Revenue | 30.10M | -- | -- | -- | 16.85M |
| Total Revenue | 384.81M | 345.25M | 355.79M | 373.23M | 370.69M |
| Cost of Revenue | 426.06M | 369.79M | 351.35M | 372.04M | 410.22M |
| Gross Profit | -41.24M | -24.54M | 4.44M | 1.18M | -39.54M |
| SG&A Expenses | 36.21M | 22.39M | 23.45M | 25.18M | 25.63M |
| Depreciation & Amortization | 21.00M | 21.03M | 21.08M | 21.05M | 21.15M |
| Other Operating Expenses | 55.41M | -23.74M | -5.97M | -6.96M | 37.93M |
| Total Operating Expenses | 538.68M | 389.48M | 389.91M | 411.31M | 494.93M |
| Operating Income | -153.87M | -44.22M | -34.12M | -38.09M | -124.25M |
| Income Before Tax | -166.75M | -69.45M | -41.68M | -43.17M | -124.20M |
| Income Tax Expenses | -1.04M | 11.00K | 1.98M | 1.07M | 4.95M |
| Earnings from Continuing Operations | -165.71M | -69.46M | -43.67M | -44.25M | -129.15M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 90.20M | 37.87M | 23.30M | 23.77M | 70.53M |
| Net Income | -75.52M | -31.59M | -20.36M | -20.48M | -58.62M |
| EBIT | -153.87M | -44.22M | -34.12M | -38.09M | -124.25M |
| EBITDA | -132.87M | -23.19M | -13.04M | -17.04M | -103.09M |
| EPS Basic | -23.02 | -9.67 | -6.23 | -6.28 | -25.14 |
| Normalized Basic EPS | -4.24 | -1.69 | -0.84 | -0.99 | -2.78 |
| EPS Diluted | -46.04 | -9.67 | -6.23 | -6.28 | -29.04 |
| Normalized Diluted EPS | -6.18 | -1.69 | -0.84 | -0.99 | -2.78 |
| Average Basic Shares Outstanding | 3.28M | 3.27M | 3.27M | 3.26M | 2.33M |
| Average Diluted Shares Outstanding | 10.48M | 3.27M | 3.27M | 3.26M | 2.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |